tiprankstipranks
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
US Market
MRKR
Marker Therapeutics
RESEARCH TOOLSreports

Marker Therapeutics (MRKR) Financial Statements

602 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently $22.01M. The company's EPS TTM is $-0.1; its P/E ratio is -1.88; Marker Therapeutics is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.55M$ 6.59M$ 3.31M$ 3.51M$ 1.24M
Gross Profit$ 0.00$ -6.88M$ -7.11M$ -8.45M$ -1.92M
Operating Income$ -12.44M$ -11.12M$ -14.58M$ -19.79M$ -39.48M
EBITDA$ -12.44M$ -11.12M$ -11.79M$ -17.00M$ -38.72M
Net Income$ -12.16M$ -10.73M$ -8.24M$ -29.93M$ -41.88M
Balance Sheet
Cash & Short-Term Investments$ 16.07T$ 19.19M$ 15.11M$ 11.78M$ 42.35M
Total Assets$ 19.07T$ 22.02M$ 17.13M$ 34.42M$ 68.14M
Total Debt$ 0.00$ 0.00$ 0.00$ 7.62M$ 11.87M
Net Debt$ -16.07T$ -19.19M$ -15.11M$ -4.17M$ -30.48M
Total Liabilities$ 2.27T$ 3.46M$ 3.07M$ 14.82M$ 24.15M
Stockholders' Equity$ 16.80T$ 18.56M$ 14.05M$ 19.60M$ 43.99M
Cash Flow
Free Cash Flow$ -12.01T$ -10.91M$ -16.44M$ -26.97M$ -30.41M
Operating Cash Flow$ -12.01T$ -10.91M$ -16.44M$ -26.97M$ -27.28M
Investing Cash Flow$ 0.00$ 0.00$ 18.66M$ -4.95M$ -3.13M
Financing Cash Flow$ 9.86T$ 14.99M$ 1.11M$ 202.13K$ 52.56M
Currency in USD

Marker Therapeutics Earnings and Revenue History

Income Statement >

Marker Therapeutics Debt to Assets

Balance Sheet >

Marker Therapeutics Cash Flow

Cash Flow >

Marker Therapeutics Forecast EPS vs Actual EPS

Earnings >